坦索罗辛与其他药物联合用药治疗输尿管结石的研究进展

Research Progress of Tamsulosin Combined with Other Drugs in the Treatment of Ureteral Calculi

坦索罗辛作为高选择性α1受体抑制剂,是临床上治疗前列腺良性增生的主要药物,与其他药物联合使用治疗输尿管结石成为研究热点,受到了国内外许多专家和学者本的广泛关注。文章系统总结了坦索罗辛与其他药物联合用药的疗效情况,旨在为寻求当前探索所遇到的问题以及未来研究的趋势,为该领域的进一步研究提供参考。

Tamsulosin,as a highly selectiveα1 receptor inhibitor,is the main drug for the treatment of benign prostatic hyperplasia in clinic.The combination of tamsulosin and other drugs in the treatment of ureteral calculi has become a research hotspot,which has attracted extensive attention of many experts and scholars at home and abroad.This article systematically summarizes the efficacy of tamsulosin combined with other drugs,aiming at seeking the problems encountered in current exploration and future research trends,and providing a reference for further research in this field.